West Pharma Executive Sees SmartDose 3.5 as 290-Basis-Point 2027 Growth Headwind
A West Pharma executive said SmartDose 3.5 revenue will be about a 290-basis-point headwind to reported growth in 2027.
Related stories
Philex Mining Reports Q3 Core Net Income of 537 Million Pesos
M impact | EARNINGS | Oct 30, 2026, 12:34 AM UTC
Fujitsu plunges after first-half net profit declines
Fujitsu reported a year-over-year decline in consolidated net profit for April–September. Its shares fell sharply.
M impact | EARNINGS | Oct 30, 2026, 12:29 AM UTC
China CITIC Bank earnings below expectations at 0.29 CNY
China CITIC Bank (601998) released earnings per share at 0.29 CNY, compared to market expectations of 0.32 CNY.
H impact | EARNINGS | Oct 30, 2026, 12:28 AM UTC
Sinopec earnings above expectations at 0.11 CNY
Sinopec (600028) released earnings per share at 0.11 CNY, compared to market expectations of 0.04 CNY.
H impact | EARNINGS | Oct 30, 2026, 12:28 AM UTC
GigaDevice Semiconductor earnings above expectations at 5.94 CNY
GigaDevice Semiconductor (603986) released earnings per share at 5.94 CNY, compared to market expectations of 2.44 CNY.
H impact | EARNINGS | Oct 30, 2026, 12:28 AM UTC
Fujitsu earnings below expectations at 27.61 JPY
Fujitsu (6702) released earnings per share at 27.61 JPY, compared to market expectations of 29.63 JPY.
H impact | EARNINGS | Oct 30, 2026, 12:28 AM UTC